Fluit C R, Kunst V A, Drenthe-Schonk A M
Blood Transfusion Service, St. Radboud University Hospital, Nijmegen, The Netherlands.
Transfusion. 1990 Jul-Aug;30(6):532-5. doi: 10.1046/j.1537-2995.1990.30690333485.x.
A retrospective study was performed to estimate the frequency of alloimmunization against red cell (RBC) antigens in a multiply transfused group. Patients (n = 186) were studied who had received at least six blood transfusions during a period of at least 3 months. Some 6944 units of blood were transfused. One hundred forty patients had hematologic disorders. The patients' sera were investigated every 3 months with indirect antiglobulin tests and enzyme-treated RBCs. Twenty-two patients (11.8%) made 33 antibodies. Seven patients made more than one antibody. Eight of the 22 patients (36.4%) made their first antibody before or at the 10th transfusion. The risk of immunization increased with the number of transfusions. Influence of gender and age was not demonstrable. Nor was a relationship demonstrated between blood transfusion reactions and RBC antibody formation; no delayed hemolytic transfusion reactions occurred. Anti-E was demonstrated in 12 patients and anti-K in 15. When the gene frequencies were taken into account, it appeared that anti-E was made by 11.5 percent of E-negative patients, most of whom were immunized after an estimated three transfusions with E-positive blood. Anti-K was made by 8.7 percent of the K-negative patients, after an estimated 2.1 units of K-positive blood. It might be desirable to match red cell units for the E and K antigens in patients at relatively high risk. These are primarily patients who have already formed an antibody and are going to receive many transfusions and women of childbearing age who are to receive more than 4 units of blood.
开展了一项回顾性研究,以评估多次输血患者群体中红细胞(RBC)抗原同种免疫的发生率。研究对象为在至少3个月内接受过至少6次输血的患者(n = 186)。共输注了约6944单位血液。其中140例患者患有血液系统疾病。每隔3个月采用间接抗球蛋白试验和酶处理红细胞对患者血清进行检测。22例患者(11.8%)产生了33种抗体。7例患者产生了不止一种抗体。22例患者中有8例(36.4%)在第10次输血前或输血时产生了第一种抗体。免疫风险随着输血量的增加而升高。未证实性别和年龄的影响。也未证实输血反应与红细胞抗体形成之间存在关联;未发生迟发性溶血性输血反应。12例患者检测到抗-E,15例检测到抗-K。考虑基因频率后发现,11.5%的E阴性患者产生了抗-E,其中大多数在输注约3次E阳性血液后产生免疫。8.7%的K阴性患者产生了抗-K,在输注约2.1单位K阳性血液后产生。对于风险相对较高的患者,可能需要对红细胞单位进行E和K抗原配型。这些患者主要是已经产生抗体且即将接受多次输血的患者以及将要接受超过4单位血液的育龄期女性。